伏立康唑治疗急性髓系白血病诱导化疗期肺部侵袭性真菌感染的疗效被引量：8

下载PDF

导出

摘要目的观察伏立康唑对急性髓系白血病诱导化疗期肺部侵袭性真菌感染的临床治疗效果。方法选取该院2012年1月至2016年9月收治的40例急性髓系白血病化疗后发生肺部侵袭性真菌感染的患者作为研究对象,观察患者使用伏立康唑治疗后的临床疗效。结果治疗后患者有效率为82.5%(33/40)。其中痊愈32.5%(13/40),显效22.5%(9/40),进步27.5%(11/40),无效17.5%(7/40)。此疗效与白血病患者的性别、年龄无关,与预后分层、化疗疗效有关。结论可选择伏立康唑治疗急性髓系白血病诱导化疗后肺部真菌感染,其效果显著,经济性较高,可推广使用。

作者李佳佳朱俊锋朱凯张竞竞

机构地区蚌埠医学院第一附属医院血液科蚌埠医学院第一附属医院肿瘤内科

出处《中国老年学杂志》 CAS 北大核心 2017年第7期1661-1663,共3页 Chinese Journal of Gerontology

基金国家自然科学基金(81071942) 安徽省高等学校自然科学研究项目(KJ2015B088by) 蚌埠医学院院级课题基金(BYKY1470)

关键词伏立康唑急性髓系白血病诱导化疗侵袭性真菌感染

分类号 R733.7 [医药卫生—肿瘤]

引文网络
相关文献

参考文献2

1徐晓鸿,陈家斌,夏银稳.两性霉素B对老年白血病化疗后肺部侵袭性真菌感染的疗效研究[J].临床肺科杂志,2016,21(7):1204-1206. 被引量：7
2李吉明,彭鹏,李文超.伏立康唑和氟康唑早期经验性治疗真菌感染的疗效比较[J].临床肺科杂志,2012,17(3):439-440. 被引量：12

二级参考文献19

1王红兰.肺部真菌感染48例临床分析[J].临床肺科杂志,2007,12(8):861-861. 被引量：25
2Chowdhry R,Marshall WL.Antifungal therapies in the intensive care unit[J].Intensive Care Med,2008,23(3):151-158.
3Parkins MD,Sabuda DM,Elsayed S,et al.Adequacy of empirical antifungal therapy and effect of outcome among patients with invasive Candida species infections[J].Antimicrob Chemother,2007,60(3):613-618.
4Scott LJ,Simpson D.Voriconazole:a review of its use in the management of invasive fungal infections[J].Drugs,2007,67:269-298.
5Kontoyiannis DP,Marr KA,Park B J,et al.Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients,2001-2006:overview of the Transplant-Associated Infection Surveillance Network(TRANS-NET)Database[J].Clin Infect Dis,2010,50:1091-1100.
6Anaissie E, Mattiuzzi G C, Noskin G, et al. Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion [ J]. Antimicrobial Agents & Chemotherapy, 2013, 42(3) :606 -611.
7Mattiuzzi G N, Hagop K, Stefan F, et al. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome under- going induction chemotherapy. [ J]. Cancer, 2014, 100 (3) :581 - 589.
8Martino P, Girmenia C. Diagnosis and treatment of invasive fungal infections in cancer patients. [ J]. Supportive Care in Cancer Offi- cial Journal of the Multinational Association of Supportive Care in Cancer, 2013, 1 (5) :240 -4.
9Chopra R, Fielding A, Goldstone A H. Successful treatment of fungal infections in neutropenic patients with liposomal amphoteri- cin (AmBisome)--a report on 40 cases from a single centre. [ J]. Leukemia & Lymphoma, 2012, 7 (20) :73 -77.
10Luong ML, Filion C, Labbe AC, et al. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with he- matologic malignancies [ J ]. Diagn Microbiol Infect Dis, 2014,68 (2) : 132-139.